ArticleThe Journal of urology2025

Novel Intraprostatic Magnetic Resonance-Guided Implantation of Multidrug-Eluting Microdevice for Testing of Systemic Therapy Agents In Situ: Proof of Concept in Intermediate-Risk and High-Risk Prostate Cancer.

Benjamin V Stone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.